|
|
 |
|
Viewing report
|
|
|
|
Emerging Technology Developments in Hybrid Imaging
Frost & Sullivan, Sep 2010, Pages: 79
This research service evaluates the emerging trends and future application scenarios pertaining to the hybrid imaging technology space in healthcare. The research offers an analysis of technology capabilities, and provides insights on technology value chain, drivers, restraints and challenges, diffusion of innovations assessment which include application-wise and region-wise adoption potential of the various hybrid imaging modalities discussed, analysis of end user demands, opportunities and strategic recommendations. Finally a list of patents pertaining to hybrid scanners and radiopharmaceuticals along with decision support tables completes the study
Research Overview
This Frost & Sullivan research service titled Emerging Technology Developments in Hybrid Imaging provides an in-depth analysis of the market drivers and restraints, industry trends, and competitive environment in addition to the challenges and issues faced by market participants. The research also provides notable advances in the hybrid scanner segment and market penetration potential of technologies such as positron emission tomography- computed tomography (PET-CT), single photon emission computed tomography (SPECT-CT) and future potential of positron emission tomography - magnetic resonance imaging (PET-MRI) systems for preclinical imaging, with strategic recommendations, end-user analysis, and opportunity analysis.
This analysis is available through our Technical Insights program. With this program, clients receive industry-leading market research along with comprehensive, objective information that allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth.
Technology Overview
Technology Developments and Superior Diagnostic Capabilities Drive the Hybrid Scanners Market
Hybrid imaging systems such as PET-CT have gained widespread recognition among the medical oncology community and major OEMs no longer offer stand-alone PET scanners. With PET-CT hybrids currently becoming the standard imaging tool for oncology exams, SPECT-CT devices have begun to be adopted by the nuclear medicine community, driven by the benefits of hybrid imaging experienced through PET-CT. Though PET-CT hybrids have experienced slower adoption, the use of SPECT-CT systems is on the rise; this is beginning to affect the sales of stand-alone SPECT systems. In addition, recent developments in solid-state detectors have enabled PET integration with MRI scanners and as a result, prototype PET-MRI devices have sprung up for immediate utilization for preclinical imaging. Moreover, another hybrid that combines SPECT with MRI is expected to be available soon. These hybrid systems expedite the delivery of complementary anatomical, functional, and molecular information to enable high levels of accuracy in diagnosis that individual modalities cannot offer. “Increase in disease incidence, demand for complementary information by clinicians for effective disease management, development of new PET and SPECT radiotracers and advances in sold state detectors used in these systems are factors providing traction for the market,” notes the analyst of this research service. “A new era is opening up for disease imaging, where hybrid imaging will be the primary diagnostic tool, merging with molecular imaging.”
Issues surrounding cost have restrained market progression. The cost of a PET/CT fusion scanner ranges anywhere between $1.9 million and $2.4 million, depending on the system configuration; however, this does not include the additional costs for extended interpretation times required by the radiologists. This is much larger than for a stand-alone PET or CT and therefore, limits its availability in small medical imaging clinics and rural setups, as only multispecialty hospitals and larger clinical setups can afford to install high-end hybrid systems. One way to offset this is to increase patient throughput by optimizing the modality usage. This can be done by applying it to several clinical indications. This is further going to drive the trend toward multipurpose hybrid scanners having high-end systems of both modalities. With regards to PET–MRI, the cost of the machine is expected to be anywhere between $2.5 million to $3 million. This calls for a cost-benefit evaluation of the technology to see if there are actual cost offsets gained on account of faster imaging.
To remain competitive in this arena, manufacturers must resort to technological innovation to help simplify the task for radiologists. The time-of-flight (TOF) introduction by a major OEM is a noteworthy innovation that maintains product lifecycle and justifies costs. Adopting innovative strategies will ensure breakeven points for vendors due to alarming increase in disease (cancer, heart disease) incidence through increase in procedure volumes. “Setting up a local OEM base and partnering with hospital chains will help enhance market prospects,” says the analyst. “Major OEMs such as General Electric Company, Koninklijke Philips Electronics N.V.,, and Siemens AG must establish imaging research centers or manufacturing divisions in Asia to ramp up technology/product awareness and ensure availability at lower system costs.” In this direction, GE Healthcare has invested $15 million to manufacture PET/CT systems in India. Additionally, OEMs must proactively partner with large hospital groups in countries such as Malaysia, Singapore, India, and Australia to maximize product visibility and outreach in these regions.
Frost & Sullivan Growth Partnership Service
Frost & Sullivan's Growth Partnership Services empower companies to accelerate their growth by achieving top-line improvements and bottom-line results. This is accomplished by helping our clients execute successful growth strategies and providing their Growth Teams™ with the skills, know-how, and tools to generate growth opportunities, evaluate these opportunities to create a growth pipeline, and implement a growth strategy to deliver measurable business results.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Advanced PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Global Market (2010 -2015)
Radiopharmaceuticals - Global Strategic Business Report
Advances in CT Technologies (Technical Insights)
European Molecular Imaging Markets
European Computed Tomography (CT) Systems Markets
North American Computed Tomography (CT) Imaging Equipment Markets
Strategic Analysis of the European Computer Aided Detection (CAD) Systems Markets
Computed Tomography Scanner Market in India 2011
Strategic Analysis of European Market for Low Cost OEM Navigation Systems
World Market for Semiconductors in Medical Imaging
|
|
|
|
